<?xml version="1.0" encoding="UTF-8"?>
<p>Hepatitis B virus (HBV) infection is a serious global health problem, with 2 billion people infected worldwide and 350 million suffering from chronic HBV infection. The tenth leading cause of death worldwide, HBV infections result in 500,000–1.2 million deaths per year caused by chronic hepatitis, cirrhosis, and hepatocellular carcinoma; the last accounts for 320,000 deaths per year (WHO Report.3 
 <xref ref-type="bibr" rid="CR180">1997</xref>; WHO fact sheet 
 <xref ref-type="bibr" rid="CR181">2000</xref>). Hepatitis B virus (HBV) infection is a major global public health problem. Of the approximately 2 billion people who have been infected worldwide, more than 350 million act as chronic carriers of HBV (WHO fact sheet 
 <xref ref-type="bibr" rid="CR181">2000</xref>). Approximately 15–40 % of infected patients will develop cirrhosis, liver failure, or hepatocellular carcinoma (Lok 
 <xref ref-type="bibr" rid="CR105">2002</xref>). HBV infection accounts for 500,000–1.2 million deaths each year (Mahoney 
 <xref ref-type="bibr" rid="CR106">1999</xref>; Lee 
 <xref ref-type="bibr" rid="CR96">1997</xref>) and is the tenth leading cause of death worldwide.
</p>
